Construction of a Large Phage-Displayed Human Antibody Domain Library with a Scaffold Based On a Newly Identified Highly Soluble, Stable Heavy Chain Variable Domain-Reference-Cited by-同舟云学术

Construction of a Large Phage-Displayed Human Antibody Domain Library with a Scaffold Based On a Newly Identified Highly Soluble, Stable Heavy Chain Variable Domain

Published:2008-10 Issue:3 Volume:382 Page:779-789
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Chen Weizao,Zhu Zhongyu,Feng Yang,Xiao Xiaodong,Dimitrov Dimiter S.

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference13 articles.

1. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli;Ward;Nature,1989

2. Domain antibodies: proteins for therapy;Holt;Trends Biotechnol.,2003

3. Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains;Muyldermans;Trends Biochem. Sci.,2001

4. Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries;Soderlind;Nat. Biotechnol.,2000

5. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold;Lee;J. Mol. Biol.,2004

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pComb3 Phagemid Family of Phage Display Vectors;Cold Spring Harbor Protocols;2023-07-17

2. The CD47-SIRPα axis is a promising target for cancer immunotherapies;International Immunopharmacology;2023-07

3. Identification and Characterization of Nanobodies from a Phage Display Library and Their Application in an Immunoassay for the Sensitive Detection of African Swine Fever Virus;Journal of Clinical Microbiology;2023-06-20

4. Good multiple sclerosis (MS) care and how to get there in Canada: Perspectives of Canadian healthcare providers working with persons with MS;Frontiers in Neurology;2023-03-02

5. Therapeutic Protein-Based Vaccines;Protein-based Therapeutics;2023